Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hyaluronan control of the primary vascular barrier during early mouse pregnancy is mediated by uterine NK cells
Ron Hadas, Eran Gershon, Aviad Cohen, Ofir Atrakchi, Shlomi Lazar, Ofra Golani, Bareket Dassa, Michal Elbaz, Gadi Cohen, Raya Eilam, Nava Dekel, Michal Neeman
Ron Hadas, Eran Gershon, Aviad Cohen, Ofir Atrakchi, Shlomi Lazar, Ofra Golani, Bareket Dassa, Michal Elbaz, Gadi Cohen, Raya Eilam, Nava Dekel, Michal Neeman
View: Text | PDF
Research Article Angiogenesis Reproductive biology

Hyaluronan control of the primary vascular barrier during early mouse pregnancy is mediated by uterine NK cells

  • Text
  • PDF
Abstract

Successful implantation is associated with a unique spatial pattern of vascular remodeling, characterized by profound peripheral neovascularization surrounding a periembryo avascular niche. We hypothesized that hyaluronan controls the formation of this distinctive vascular pattern encompassing the embryo. This hypothesis was evaluated by genetic modification of hyaluronan metabolism, specifically targeted to embryonic trophoblast cells. The outcome of altered hyaluronan deposition on uterine vascular remodeling and postimplantation development were analyzed by MRI, detailed histological examinations, and RNA sequencing of uterine NK cells. Our experiments revealed that disruption of hyaluronan synthesis, as well as its increased cleavage at the embryonic niche, impaired implantation by induction of decidual vascular permeability, defective vascular sinus folds formation, breach of the maternal-embryo barrier, elevated MMP-9 expression, and interrupted uterine NK cell recruitment and function. Conversely, enhanced deposition of hyaluronan resulted in the expansion of the maternal-embryo barrier and increased diffusion distance, leading to compromised implantation. The deposition of hyaluronan at the embryonic niche is regulated by progesterone-progesterone receptor signaling. These results demonstrate a pivotal role for hyaluronan in successful pregnancy by fine-tuning the periembryo avascular niche and maternal vascular morphogenesis.

Authors

Ron Hadas, Eran Gershon, Aviad Cohen, Ofir Atrakchi, Shlomi Lazar, Ofra Golani, Bareket Dassa, Michal Elbaz, Gadi Cohen, Raya Eilam, Nava Dekel, Michal Neeman

×

Figure 5

Trophectoderm overexpression of Hyal-2 resulted in enhanced implantation rate but early embryonic lethality.

Options: View larger image (or click on image) Download as PowerPoint
Trophectoderm overexpression of Hyal-2 resulted in enhanced implantation...
Implantation sites were studied at E6.5, containing sham-infected embryos and embryos overexpressing Hyal-2 in their trophoblast. (A) H&E staining (n = 6 dams; white arrows indicate decidua). (B) TUNEL staining revealed cell death at the embryonic niche of Hyal-2 OEx (white arrow indicate embryonic cells; n = 4 dams). (C and D) Quantification of observed decidua, as well as their calculated area (2.9 ± 0.5; 4.75 ± 0.7; P = 0.02) (n = 12 dams in control, n = 10 dams in Hyal-2 OEx) divided by (3.42-fold change± 0.07; 0.03; P = 0.0006) (n = 8 dams, 27 implantation sites in control; n = 6 dams, 23 implantation sites for Hyal-2 OEx). (E and F) Detection of MAC-2+ macrophages and their quantification (5.9-fold change ± 0.35; P = 0.02) (n = 5 dams, 9 decidua in each group). (G) Presence of MAC-2+ macrophages was further demonstrated using immunostaining of macrophages in implantation sites harvested from surrogate mothers injected with rhodamine-labeled (ROX-labeled) lectin. Tissues were made transparent using modified tissue clearing procedure, thus enabling visualization of whole decidua by confocal microscopy. (n = 2 dams from each group). (H) Flow cytometry analysis of CD11b+F4/80+ cells in E6.5 decidua (12.33 ± 0.31 [control]; 17.02 ± 1.49 [overexpression]; P = 0.04) (n = 3 dams in control, n = 5 dams in Hyal-2 OEx). The statistical analysis applied was Student’s t test (C, D, F, and H).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts